{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/fda/warning-letters/check?name=Cooper%20Institute","name":"Cooper Institute","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-08-12T17:05:43.262Z"},"count":1,"matches":[{"id":"c2418c90b8c2e3e0","posted_date":"2021-12-14","letter_issue_date":"2021-12-15","company_name":"Cooper Institute","issuing_office":"Office of Biological Products Operations – Division 2","subject":"Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)","canonical_url":"https://api.ai-analytics.org/fda-warning/c2418c90b8c2e3e0"}]}